Israel Englander Bristol Myers Squibb CO Put Options Transaction History

Millennium Management LLC

8 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$39.66 - $51.75 $8.96 Million - $11.7 Million	225,900 Added 97.16%	458,400 $23.7 Million
Q2 2024 Aug 14, 2024	SELL	$40.25 - $52.99 $5.53 Million - $7.28 Million	-137,300 Reduced 37.13%	232,500 $9.66 Million
Q1 2024 May 15, 2024	BUY	$47.98 - $54.4 $4.19 Million - $4.75 Million	87,300 Added 30.9%	369,800 $20.1 Million
Q4 2023 Feb 14, 2024	SELL	$48.48 - $57.85 $15.5 Million - $18.5 Million	-319,700 Reduced 53.09%	282,500 $14.5 Million
Q2 2023 Aug 14, 2023	BUY	$63.71 - $70.74 $891,940 - $990,359	14,000 Added 2.38%	602,200 $38.5 Million
Q1 2023 May 15, 2023	SELL	$65.71 - $74.53 $23.1 Million - $26.3 Million	-352,300 Reduced 37.46%	588,200 $40.8 Million
Q4 2022 Feb 14, 2023	BUY	$68.48 - $81.09 $6.13 Million - $7.26 Million	89,500 Added 10.52%	940,500 $67.7 Million
Q3 2022 Nov 14, 2022	SELL	$0.13 - $76.84 $68,991 - $40.8 Million	-530,700 Reduced 38.41%	851,000 $60.5 Million

2,533

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $125B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.